NCT01129596已完成不适用
Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10,238
- 主要终点
- The transition of clinical condition is evaluated comparing the result of HDS-R,MMSE with the time of study initiation
研究概览
简要总结
The purpose of this study is to investigate the following about donepezil hydrochloride administration in patients with mild or moderate Alzheimer's Disease in clinical practice: cognitive function, Functional Assessment Staging (FAST) score, adverse events/adverse drug reactions, and patient background.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
1
干预措施: donepezil hydrochloride (Drug)
结局指标
主要结局
The transition of clinical condition is evaluated comparing the result of HDS-R,MMSE with the time of study initiation
时间窗: 48 months(12 weeks and every 6 months)
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's DiseaseAlzheimer's DiseaseNCT01251718Eisai Co., Ltd.894
已完成
不适用
Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).Dementia With Lewy Body DiseaseNCT02448784Eisai Co., Ltd.591
未知
Unknown
Post-marketing surveillance of donepezil hydrochloride -Investigation of the clinical safety and effectiveness in patients with Alzheimer's DiseaseAlzheimer's DiseaseJPRN-jRCT1080221997Eisai Co., Ltd.1,000
未知
Unknown
Post-marketing surveillance of donepezil hydrochloride Dementia with Lewy bodies/long-term administratioDementia with Lewy bodiesJPRN-jRCT1080222854Eisai Co., Ltd.500
未知
Unknown
Investigation of the safety and effectiveness of combination therapy of donepezil hydrochloride and memantine hydrochloride in patients with Alzheimer's DiseaseAlzheimer's DiseaseJPRN-jRCT1080222139Eisai Co., Ltd.5,000